Filing Details
- Accession Number:
- 0000905148-24-002946
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-06 15:15:40
- Reporting Period:
- 2024-11-05
- Accepted Time:
- 2024-11-06 15:15:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1439725 | Biodesix Inc | BDSX | Services-Medical Laboratories (8071) | 203986492 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1830773 | Jr T. Lawrence Kennedy | 1700 Madison Road, Suite 200 Cincinnati OH 45206 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-05 | 51,200 | $1.37 | 10,356,024 | No | 4 | P | Indirect | By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 |
Common Stock | Acquisiton | 2024-11-06 | 20,000 | $1.36 | 10,376,024 | No | 4 | P | Indirect | By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 |
No | 4 | P | Indirect | By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 12,267,873 | Indirect | By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 |
Common Stock | 2,775,386 | Indirect | By: KFDI-B LLC |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3564 to $1.3599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.